197 related articles for article (PubMed ID: 29360939)
21. Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis.
Suputtamongkol Y; Premasathian N; Bhumimuang K; Waywa D; Nilganuwong S; Karuphong E; Anekthananon T; Wanachiwanawin D; Silpasakorn S
PLoS Negl Trop Dis; 2011 May; 5(5):e1044. PubMed ID: 21572981
[TBL] [Abstract][Full Text] [Related]
22. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases.
Datry A; Hilmarsdottir I; Mayorga-Sagastume R; Lyagoubi M; Gaxotte P; Biligui S; Chodakewitz J; Neu D; Danis M; Gentilini M
Trans R Soc Trop Med Hyg; 1994; 88(3):344-5. PubMed ID: 7974685
[TBL] [Abstract][Full Text] [Related]
23. Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantation.
Wirk B; Wingard JR
Transpl Infect Dis; 2009 Apr; 11(2):143-8. PubMed ID: 19144095
[TBL] [Abstract][Full Text] [Related]
24. Is strongyloidiasis currently autochthonous in Croatia? A retrospective study.
Balen Topić M; Marjanović E; Tomasović D; Sviben M
Trans R Soc Trop Med Hyg; 2021 Nov; 115(11):1298-1303. PubMed ID: 34520539
[TBL] [Abstract][Full Text] [Related]
25. Influence of parasite load on the diagnosis and occurrence of eosinophilia in alcoholic patients infected with Strongyloides stercoralis.
Silva MLS; Inês EJ; Souza JN; Souza ABS; Dias VMS; Oliveira LN; Guimarães CM; Menezes ER; Barbosa LG; Alves MCM; Teixeira MCA; Soares NM
J Helminthol; 2019 Jan; 93(1):21-25. PubMed ID: 29179791
[TBL] [Abstract][Full Text] [Related]
26. [Strongyloidiasis in nephrologic patients].
Gravellone L; Battaglia C; Caligara F; D'Amato I; Gandini E; Lucatello A; Rizzo MA; Torpia R; Brigante G; Castiglioni A
G Ital Nefrol; 2015; 32(2):. PubMed ID: 26005937
[TBL] [Abstract][Full Text] [Related]
27. Eosinophilic oophoritis: association with positive Strongyloides stercoralis serology and clinical response to ivermectin.
Butterfield JH; Kephart GM; Frankson JL
J Pediatr Adolesc Gynecol; 2006 Oct; 19(5):329-32. PubMed ID: 17060015
[TBL] [Abstract][Full Text] [Related]
28. Hyperinfection by Strongyloides stercoralis probably associated with Rituximab in a patient with mantle cell lymphoma and hyper eosinophilia.
Incani RN; Hernández M; González ME
Rev Inst Med Trop Sao Paulo; 2010; 52(4):221-4. PubMed ID: 21748232
[TBL] [Abstract][Full Text] [Related]
29. Molecular typing of
Repetto SA; Quarroz Braghini J; Risso MG; Argüello LB; Batalla EI; Stecher DR; Sierra MF; Burgos JM; Radisic MV; González Cappa SM; Ruybal P
Parasitology; 2022 Jan; 149(1):24-34. PubMed ID: 35184784
[TBL] [Abstract][Full Text] [Related]
30. [Infection due to Strongyloides stercoralis: epidemiological, clinical, diagnosis findings and outcome in 30 patients].
Corti M; Villafañe MF; Trione N; Risso D; Abuín JC; Palmieri O
Rev Chilena Infectol; 2011 Jun; 28(3):217-22. PubMed ID: 21879146
[TBL] [Abstract][Full Text] [Related]
31. Late post-kidney transplant Strongyloides hyperinfection syndrome.
Nishio Lucar A; Knicely DH; Sifri CD
Transpl Infect Dis; 2018 Dec; 20(6):e12975. PubMed ID: 30107075
[TBL] [Abstract][Full Text] [Related]
32. Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis.
Bisoffi Z; Buonfrate D; Angheben A; Boscolo M; Anselmi M; Marocco S; Monteiro G; Gobbo M; Bisoffi G; Gobbi F
PLoS Negl Trop Dis; 2011 Jul; 5(7):e1254. PubMed ID: 21814588
[TBL] [Abstract][Full Text] [Related]
33. Treatment strategies in controlling strongyloidiasis.
Satoh M; Kokaze A
Expert Opin Pharmacother; 2004 Nov; 5(11):2293-301. PubMed ID: 15500376
[TBL] [Abstract][Full Text] [Related]
34. Decrease in eosinophilia as a marker of response to therapy in solid organ transplant candidates with Strongyloides infection: A single-center experience.
Simkins J; Anjan S; Camargo JF
Transpl Infect Dis; 2018 Oct; 20(5):e12954. PubMed ID: 29896920
[No Abstract] [Full Text] [Related]
35. Diagnostic yield of double-balloon enteroscopy with intestinal juice analysis for intestinal strongyloidiasis.
Nakamura N; Matsushita M; Tahashi Y; Shimatani M; Aoi K; Yanagawa M; Okazaki K
Dig Endosc; 2010 Oct; 22(4):370-2. PubMed ID: 21175501
[TBL] [Abstract][Full Text] [Related]
36. Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan.
Toma H; Sato Y; Shiroma Y; Kobayashi J; Shimabukuro I; Takara M
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):147-51. PubMed ID: 11023084
[TBL] [Abstract][Full Text] [Related]
37. Type 2 Diabetes Mellitus Is Associated with Strongyloides stercoralis Treatment Failure in Australian Aboriginals.
Hays R; Esterman A; McDermott R
PLoS Negl Trop Dis; 2015; 9(8):e0003976. PubMed ID: 26295162
[TBL] [Abstract][Full Text] [Related]
38. Wait!!! No Steroids for this Asthma….
Alsharif A; Sodhi A; Murillo LC; Headley AS; Kadaria D
Am J Case Rep; 2015 Jun; 16():398-400. PubMed ID: 26114594
[TBL] [Abstract][Full Text] [Related]
39. Prevention of strongyloides hyperinfection syndrome: a rheumatological point of view.
Santiago M; Leitão B
Eur J Intern Med; 2009 Dec; 20(8):744-8. PubMed ID: 19892301
[TBL] [Abstract][Full Text] [Related]
40. A case of Strongyloides hyperinfection syndrome in the setting of persistent eosinophilia but negative serology.
Osiro S; Hamula C; Glaser A; Rana M; Dunn D
Diagn Microbiol Infect Dis; 2017 Jun; 88(2):168-170. PubMed ID: 28377165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
